Dr. Janmohamed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Heart Failure/Pulmonary Hypertension Clinic
3939 J Street, Suite 230
Sacramento, CA 95819Phone+1 916-453-2640Fax+1 916-452-1077- Is this information wrong?
Summary
Education & Training
- University of California (San Francisco) School of MedicineFellowship, Advanced Heart Failure and Transplant Cardiology, 2011 - 2012
- University of California (San Francisco)/FresnoFellowship, Cardiovascular Disease, 2008 - 2011
- University of Southern California/LAC+USC Medical CenterResidency, Nuclear Medicine, 2007 - 2008
- Louisiana State University School of Medicine (Baton Rouge)Residency, Internal Medicine, 2002 - 2005
- Ross University School of MedicineClass of 2002
- University of California-IrvineB.S., Biology, 1991 - 1996
Certifications & Licensure
- CA State Medical License 2005 - 2024
Awards, Honors, & Recognition
- Fellow of the Heart Failure Society of America (FHFSA) Heart Failure Society of America (HFSA)
- Mercy General Hospital Consultant of the Year Family Medicine Residency Program, 2018-2019
- Redefining Possible Award UCSF, 2017
- Join now to see all
Clinical Trials
- Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction Start of enrollment: 2017 Jan 06
- Hemodynamic-GUIDEd Management of Heart Failure Start of enrollment: 2018 Mar 15
Publications & Presentations
PubMed
- 56 citationsLong-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.David G. Rosenthal, Purvi Parwani, Tyler Murray, Bradley J. Petek, Bryan S. Benn, Teresa De Marco, Edward P. Gerstenfeld, M. Janmohamed, Liviu Klein, Byron K. Lee, Jos...> ;Journal of the American Heart Association. 2019 Sep 17
- 16 citationsTransition from treprostinil to selexipag in patients with pulmonary arterial hypertension: Case series.Sherif M. Fanous, Munir Janmohamed> ;American Journal of Health-System Pharmacy. 2018 Dec 1
- 19 citationsSafety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.Adaani E. Frost, Munir Janmohamed, Jason S. Fritz, John W. McConnell, David Poch, Terry Fortin, Chad Miller, Kelly Chin, Micah R. Fisher, Michael Eggert, Colleen McEvo...> ;The Journal of Heart and Lung Transplantation. 2019 Jan 1
- Join now to see all
Press Mentions
- How Clinicians Are Using the UpToDate Dialer Integration to Improve Patient CareJune 7th, 2021
- New Breed of Cardiologist Is Tackling Surge of Heart Failure Cases in SacramentoAugust 3rd, 2018
Professional Memberships
- Fellow
- ISHLTMember
- HFSAMember
Hospital Affiliations
- Mercy General HospitalSacramento, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: